Am J Geriatr Cardiol. 2005;14(1):35-38. A second large (N=2010) trial, Mode Selection Trial (MOST), [15] was published in 2002. This study was restricted to patients with SSS. No difference was seen ...

Patients who received a leadless pacemaker had similar rates of acute complications and survival at 30 days as those who received a transvenous VVI pacemaker, according to data presented at the ...

(HealthDay)—Intrabody, wireless unidirectional communication is possible using a leadless cardiac pacemaker (LCP) and subcutaneous implantable-cardioverter defibrillator (S-ICD), according to a letter ...

Dual‑chamber pacemakers have pacing leads in the right atrium and ventricle. They are indicated for use in the treatment of atrioventricular block in the absence of continuous atrial fibrillation, and ...

First results in human patients of a novel leadless pacemaker were presented last week at the HRS meeting in Denver by Vivek Reddy. Pacemaker leads are the most common source of complications ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

On the negative side and particularly in years past, adding an atrial lead increased the time taken for an implant procedure and made postoperative lead displacement and monitoring challenges more ...